Approval · Notice of Compliance 16110 · 2014
MED-DUTASTERIDE: Notice of Compliance 16110
Issued September 17, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16110
- Date
- September 17, 2014
- Company
- Generic Medical Partners IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Type I and II alpha-reductase inhibitor
- Canadian reference product
- AVODART (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MED-DUTASTERIDE | 02416298 | Dormant |
Medicinal ingredients
- DUTASTERIDE 0.5 MG per CAP